Abstract
It has been brought to our attention that a statement on page 155 of our recently published article,1 “Skin testing and interferon-γ release assays have no diagnostic role but are indicated to exclude M. tuberculosis if clinical suspicion is high,” is incorrect. This sentence should state, “Skin testing and interferon-γ release assays have no diagnostic role in pulmonary M. avium complex infections.” We would like to emphasize that, for the diagnosis of M. tuberculosis in particular, tuberculin skin testing (TST) and interferon-gamma release assays (IGRA) do not reliably distinguish between latent or active disease and therefore should not be used in diagnosing active M. tuberculosis.2-6 We would like to thank Jonathan Blum, MD, PhD, Chief of Infectious Disease, Kaiser Permanente Medical Center in Santa Clara, CA for clarifying this error and for review of this corrigendum. The authors would like to apologize for any inconvenience caused.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 757 |
| Number of pages | 1 |
| Journal | American Journal of Medicine |
| Volume | 130 |
| Issue number | 6 |
| DOIs |
|
| State | Published - Jun 2017 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- General Medicine
Fingerprint
Dive into the research topics of 'Corrigendum to ‘Nothing to (S)cough at: Pulmonary Mycobacterium avium complex infection’ (American Journal of Medicine (2017) 130(2) (153–156) (S0002934316310701) (10.1016/j.amjmed.2016.09.032))'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver